NCM
COCH icon

Nantahala Capital Management’s Envoy Medical COCH Stock Holding History

Nantahala Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09M Buy
+7,650,000
New +$5.22M 0.19% 98

Other funds holding COCH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nantahala Capital Management's COCH Position: Q1 2026 in Review

Nantahala Capital Management opened a new position in Envoy Medical (COCH) in Q1 2026: 7,650,000 shares worth $5.09M. The stake represents 0.19% of the portfolio and ranks #98 among its holdings.

33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Nantahala Capital Management held 7,650,000 shares of Envoy Medical worth $5.09M as of Q1 2026.
  • Envoy Medical was a new Nantahala Capital Management position in Q1 2026.
  • Envoy Medical made up 0.19% of Nantahala Capital Management's portfolio in Q1 2026, its #98 holding.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.